JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
PetMed Express
PETS
$43.4M
| $4.63M | ﹤0.01% |
101,719
+65,220
| +179% | +$2.57M |
|
|
DEL
2627
DELISTED
Deltic Timber
DEL
| $4.62M | ﹤0.01% |
50,461
+50,038
| +11,829% | +$4.58M |
|
|
WNS
2628
DELISTED
WNS Holdings
WNS
| $4.61M | ﹤0.01% |
114,746
+98,518
| +607% | +$3.87M |
|
|
SGEN
2629
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.6M | ﹤0.01% |
86,000
+36,000
| +72% | +$2.1M |
|
2630
AngloGold Ashanti
AU
$48.1B
| $4.6M | ﹤0.01% |
451,282
+417,146
| +1,222% | +$4.02M |
|
2631
TG Therapeutics
TGTX
$7.34B
| $4.59M | ﹤0.01% |
559,553
+201,928
| +56% | +$1.76M |
|
|
LCI
2632
DELISTED
Lannett Company, Inc.
LCI
| $4.58M | ﹤0.01% |
49,387
-27,140
| -35% | -$2.65M |
|
2633
Tompkins Financial
TMP
$1.45B
| $4.58M | ﹤0.01% |
56,315
+8,012
| +17% | +$680K |
|
2634
PUT
WIX.com
WIX
$3.35B
| $4.58M | ﹤0.01% |
+79,600
| New | +$4.93M |
|
2635
Pegasystems
PEGA
$5.51B
| $4.56M | ﹤0.01% |
193,344
+112,214
| +138% | +$3.01M |
|
|
TOWR
2636
DELISTED
Tower International, Inc.
TOWR
| $4.56M | ﹤0.01% |
149,237
+25,792
| +21% | +$780K |
|
2637
Hurco Companies Inc
HURC
$143M
| $4.56M | ﹤0.01% |
108,009
+2,693
| +3% | +$117K |
|
2638
PUT
Equifax
EFX
$21.8B
| $4.55M | ﹤0.01% |
38,600
| – | – |
|
|
IPCC
2639
DELISTED
Infinity Property & Casualty C
IPCC
| $4.54M | ﹤0.01% |
42,858
+26,694
| +165% | +$2.71M |
|
2640
Provident Financial Services
PFS
$3.26B
| $4.54M | ﹤0.01% |
168,300
+67,736
| +67% | +$1.84M |
|
2641
PUT
General Dynamics
GD
$106B
| $4.54M | ﹤0.01% |
22,300
+6,000
| +37% | +$1.23M |
|
|
AJRD
2642
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $4.53M | ﹤0.01% |
145,328
+42,782
| +42% | +$1.36M |
|
2643
International Bancshares
IBOC
$4.57B
| $4.53M | ﹤0.01% |
114,069
+78,476
| +220% | +$3.17M |
|
2644
Coherent
COHR
$64B
| $4.53M | ﹤0.01% |
96,356
+95,327
| +9,264% | +$4.28M |
|
|
PDCO
2645
PUT
DELISTED
Patterson Companies, Inc.
PDCO
| $4.52M | ﹤0.01% |
125,000
| – | – |
|
|
GOLD
2646
DELISTED
Randgold Resources Ltd
GOLD
| $4.51M | ﹤0.01% |
45,563
-54,544
| -54% | -$5.18M |
|
2647
CALL
BioMarin Pharmaceuticals
BMRN
$13.3B
| $4.46M | ﹤0.01% |
+50,000
| New | +$4.35M |
|
|
2648
PUT
BioMarin Pharmaceuticals
BMRN
$13.3B
| $4.46M | ﹤0.01% |
+50,000
| New | +$4.35M |
|
2649
CALL
Dominion Energy
D
$60.3B
| $4.46M | ﹤0.01% |
+55,000
| New | +$4.46M |
|
|
2650
PUT
Dominion Energy
D
$60.3B
| $4.46M | ﹤0.01% |
+55,000
| New | +$4.46M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.